M&G Investment Management’s JD.com JD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$20M Buy
688,953
+162,155
+31% +$4.39M 0.07% 131
2023
Q3
$15.3M Buy
526,798
+96,736
+22% +$3.37M 0.07% 152
2023
Q2
$14.6M Buy
430,062
+357,018
+489% +$13M 0.06% 156
2023
Q1
$3.21M Buy
73,044
+40,119
+122% +$2.07M 0.02% 275
2022
Q4
$1.84M Buy
+32,925
New +$1.66M 0.01% 302
2022
Q1
Sell
-2,074,995
Closed -$145K 492
2021
Q4
$145K Sell
2,074,995
-373,450
-15% -$29.5M 0.38% 23
2021
Q3
$176K Buy
2,448,445
+138,495
+6% +$10.2M 0.42% 21
2021
Q2
$185K Buy
2,309,950
+328,160
+17% +$24.7M 0.46% 19
2021
Q1
$166K Buy
1,981,790
+343,381
+21% +$31.5M 0.52% 16
2020
Q4
$144K Buy
1,638,409
+681,260
+71% +$56.9M 0.9% 20
2020
Q3
$74.7M Buy
957,149
+597,479
+166% +$41.5M 0.74% 39
2020
Q2
$21.6M Buy
359,670
+293,056
+440% +$14.8M 0.23% 103
2020
Q1
$2.73M Buy
+66,614
New +$2.66M 0.03% 241

Other funds holding JD

M&G Investment Management's JD Position: Q4 2023 in Review

M&G Investment Management increased its JD.com (JD) stake by 31% in Q4 2023, buying an estimated $4.39M and bringing the position to 688,953 shares worth $20M. The position accounts for 0.07% of the portfolio, ranked #131.

M&G Investment Management first reported a position in JD in Q1 2020 and has held it in 13 quarters since. The position peaked at $74.7M in Q3 2020. 451 funds tracked by Wall St. Rank hold JD as of Q4 2023.

  • M&G Investment Management held 688,953 shares of JD.com worth $20M as of Q4 2023.
  • M&G Investment Management bought 162,155 JD.com shares in Q4 2023, an estimated $4.39M.
  • JD.com made up 0.07% of M&G Investment Management's portfolio in Q4 2023, its #131 holding.
  • M&G Investment Management first reported a position in JD.com in Q1 2020 and has held it in 13 quarters since.
  • M&G Investment Management's JD.com position peaked at $74.7M in Q3 2020.
  • 451 funds tracked by Wall St. Rank held JD.com as of Q4 2023.

Based on M&G Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.